Designing the future of metabolic health through tissue-selective drug delivery
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
MIT engineers designed capsules with biodegradable radio frequency antennas that can reveal when the pill has been swallowed.
MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth following a heart attack.
Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.
Outfitted with antibodies that guide them to the tumor site, the new nanoparticles could reduce the side effects of treatment.
MIT engineers used a machine-learning model to design nanoparticles that can deliver RNA to cells more efficiently.
The mechanical system could be used to deliver drugs in the GI tract or monitor aquatic environments.
The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.
Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.
The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
Scaling up nanoparticle production could help scientists test new cancer treatments.
With tinier needles and fewer injections, the approach may enable new options for long-term delivery of contraceptives or treatments for diseases such as HIV.
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Physician and engineer Giovanni Traverso found an early passion for molecular genetics, leading to an interdisciplinary career helping others.